MedPath

Mind-body Approach and Gut Microbiota in Osteoarthritis

Not Applicable
Active, not recruiting
Conditions
Osteoarthritis
Interventions
Behavioral: Tai Chi versus wellness education
Registration Number
NCT05186714
Lead Sponsor
Tufts Medical Center
Brief Summary

This exploratory study is to compares mechanisms of mind-body exercise with wellness education program on gut microbiota for osteoarthritis as a basis for a future large-scale trial.

Detailed Description

This exploratory study is to determine the effect of mind-body exercise on gut microbiota in patients with osteoarthritis. We will randomize 80 eligible individuals who meet the American College of Rheumatology criteria for osteoarthritis into Tai Chi or wellness education interventions for 12 weeks. Using 16S rRNA amplicon sequencing of fecal DNA samples we will compare the changes in gut microbiota profiles using 16S rRNA gene amplicon sequencing, and quantity of Streptococcus species using quantitative PCR, as well as their association with clinical outcomes. This exploratory study will guide the development of theoretically informed, effective treatment for a high-risk population further enlighten us about the pathogenesis of metabolic osteoarthritis pain.This proposal will provide crucial preliminary knowledge of the mechanism underlying Tai Chi mind-body therapy for metabolic osteoarthritis.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
73
Inclusion Criteria
  • Age ≥ 55 years
  • Fulfills the American College of Rheumatology Criteria for symptomatic OA
  • Baseline (Month 0) WOMAC pain subscale score ≥ 40
Exclusion Criteria
  • Dementia, neurological disease, cancer, cardiovascular disease, renal disease, liver disease, or other serious medical conditions limiting ability to participate in the programs.
  • Factors known or likely to impact the intestinal microbiota or known to be associated with microbial translocation: antibiotic or probiotic use within the previous 4 weeks, gastrointestinal morbidity (irritable bowel syndrome, inflammatory bowel disease, history of gastrointestinal cancer or surgical resection, or acute, severe gastrointestinal symptoms requiring medical attention), opportunistic infection, and evidence of hepatitis B or C virus infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tai ChiTai Chi versus wellness education12 weeks of Tai Chi classes
Wellnes EducationTai Chi versus wellness education12 weeks of Wellness Education classes
Primary Outcome Measures
NameTimeMethod
Gut microbiotaFrom Week 0, to Week 12

Changes in gut composition, relative abundance and diversity, and Streptococcus abundance

Secondary Outcome Measures
NameTimeMethod
Arthritis Self-efficacyFrom Week 0 to Week 12

Arthritis Self-efficacy Scale score (SD) (Range, 1-10)

Patient Global, 0-100 cm VASFrom Week 0 to Week 12

Global knee pain assessment (range, 0 \[no pain\]-100 \[extreme pain\]),

Change in Hospital Anxiety and Depression ScaleFrom Week 0 to Week 12

The Hospital Anxiety and Depression Scale (range 0-21, with higher scores indicating more severe symptoms).

Change in Body mass indexFrom Week 0 to Week 12

Body mass index is measured as the weight (kg) divided by the height (m). squared

Change in Western Ontario and McMaster University Index (WOMAC)From Week 0 to Week 12

WOMAC version 3.1 questionnaire (pain subscale range, 0 \[no pain\]-20 \[extreme pain\]; the stiffness subscale range, 0 \[no stiffness\]-8 \[extreme stiffness\]; function subscale range, 0 \[no difficulty with daily activities\]-68 \[extreme difficulty\].

PROMIS-29From Week 0 to Week 12

PROMIS-29 measure assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance).

PROMIS Pain InterferenceFrom Week 0 to Week 12

PROMIS Pain Interference score (short form 6b item short form evaluating the extent to which pain interferes with physical, emotional and social activities).

Trial Locations

Locations (1)

Tufts Medical Center, Rheumatology

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath